Indaptus Therapeutics share price logo

Indaptus Therapeutics

NASDAQ: INDP

Small Cap

$3.55

-0.38

(-9.67%)

as on

Indaptus Therapeutics Stock Performance

as on September 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $3.51
    $4.08
    downward going graph

    1.13%

    Downside

    14.93%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.92
    $8.57
    downward going graph

    74.08%

    Downside

    141.41%

    Upside

    downward going graph

Indaptus Therapeutics share price movements today

Previous Close
$3.93
Open
$3.63
Volume
1.1M
Market Cap
$427.7M
Day's Low - High
$3.51 - $4.08
52 Week Low - High
$0.92 - $8.57

Indaptus Therapeutics Historical Returns

1 Month Return
+ 318.09 %
3 Month Return
+ 0.77 %
1 Year Return
+ 41.37 %
3 Year Return
-96.45 %
5 Year Return
-98.61 %

Indaptus Therapeutics Stock Fundamentals & Key Indicators

Check Indaptus Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$427.7M

EPS (TTM)

-6.97

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.52

Industry PE ratio

-6.87

PEG Ratio

-0.0026349909921546274

EBITDA

-15.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-302.75%

Indaptus Therapeutics Stock Valuation

Track how Indaptus Therapeutics P/E has moved over time to understand its valuation trends.

Indaptus Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-84.66x)

December 31, 2021

Industry (-6.87x)

December 31, 2025

Today (-0.13x)

December 31, 2025

Highest (-0.13x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.13x

Indaptus Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Indaptus Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$427.7M-98.61%-0.520.00%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Indaptus Therapeutics Stock including INR - Dollar returns

The Indaptus Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Indaptus Therapeutics investment value today

Current value as on today

₹1,38,655

Returns

₹38,655

(+38.66%)

Returns from Indaptus Therapeutics Stock

₹27,698 (+27.7%)

Dollar Impact

₹10,957 (+10.96%)

Analyst Recommendation on Indaptus Therapeutics Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Indaptus Therapeutics. Average target price of $10

Indaptus Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Indaptus Therapeutics.

What analysts predicted

64.5%UPSIDE

Target Price

$10

Current Price

$3.55

Analyzed by

8 Analysts

Target

$10.00

Indaptus Therapeutics target price $10, a slight upside of 64.5% compared to current price of $3.55. According to 8 analysts rating.

Indian Investors' Interest in Indaptus Therapeutics Stock

Investment in Indaptus Therapeutics Shares on INDmoney has grown by 370.58% in the last 30 days, indicating increased investment activity.

Time period: to

Change:370.58% versus previous 30 day period

Search interest for Indaptus Therapeutics Stock has increased by 231% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:231% versus previous 30 day period

Indaptus Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-3
-4
-3
-4
-4
-4
-2
-8
-2
-1
EBITDA
-3
-4
-3
-4
-4
-5
-2
-8
-2
-1
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
-
-
-
-
-
-
-
-
-
Income Before Tax
-3
-4
-3
-4
-4
-5
-2
-8
-2
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-4
-3
-4
-4
-5
-2
-8
-2
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Indaptus Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
-
-
-
Operating Income
-29
-43
-34
-3
-7
-14
-16
-15
-19
EBITDA
-28
-42
-46
-3
-7
-14
-15
-15
-20
Interest Expense
0
0
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
-
Income Before Tax
-28
-43
-46
-3
-7
-14
-15
-15
-20
Income Tax Expense
0
0
0
-
-
-
-
-
-
Net Income
-28
-43
-47
-3
-7
-14
-15
-15
-20
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Indaptus Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-4
-3
-4
-4
-5
-2
-8
-2
-1
Operating Cash Flow
-3
-2
-2
-3
-5
-4
-3
-3
-7
-1
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-4
Financing Cash Flow
0
0
2
1
3
6
2
5
-
11
Change in Cash
-3
-2
0
-1
-1
2
0
2
-7
6

Indaptus Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-28
-43
-47
-3
-7
-14
-15
-15
-20
Operating Cash Flow
-22
-39
-29
-3
-11
-13
-13
-12
-14
Investing Cash Flow
-4
-9
-3
-
0
-16
17
-
-
Financing Cash Flow
63
35
2
1
48
-
-
4
17
Change in Cash
36
-14
-29
-2
37
-29
3
-7
2

Mutual Funds that own Indaptus Therapeutics Stock

Check out the Mutual Funds with significant holdings in Indaptus Therapeutics.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.006813%
9078

Global Institutional Holdings in Indaptus Therapeutics

Funds
Holdings
Vanguard
0.03%
Morgan Stanley
0.01%

Insights on Indaptus Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, INDP stock has moved up by 157.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 482.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 48.8% return, outperforming this stock by 145.2%

About Indaptus Therapeutics

Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials. This candidate is being evaluated for its capacity to elicit lasting therapeutic responses, either as a standalone agent or in combination with other treatments, for various conditions including lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as infections caused by the hepatitis B virus and human immunodeficiency virus. Initially incorporated in 2021 under the name Intec Parent, Inc., the company officially rebranded to Indaptus Therapeutics, Inc. in August of the same year. Its corporate headquarters are situated in New York, New York.
OrganisationIndaptus Therapeutics
Headquarters3 Columbus Circle, New York City, NY, 10019, US
IndustryBiotechnology
CEOJunyi Dai
E-voting on sharesClick here to vote

Key Management of Indaptus Therapeutics

Name

Title

Mr. Junyi Dai

CEO & Chairman

Mr. Yu Ding

Chief Financial Officer

FAQs

What is Indaptus Therapeutics share price today?

Indaptus Therapeutics share price today is $3.55 as on at the close of the market. Indaptus Therapeutics share today touched a day high of $4.08 and a low of $3.51.

What is the 52 week high and 52 week low for Indaptus Therapeutics share?

Indaptus Therapeutics share touched a 52 week high of $8.57 on and a 52 week low of $0.92 on . Indaptus Therapeutics stock price today i.e. is closed at $3.55,which is 58.58% down from its 52 week high and 285.87% up from its 52 week low.

What is Indaptus Therapeutics's market capitalisation today?

Indaptus Therapeutics market capitalisation is $0.00T as on .

How to invest in Indaptus Therapeutics Stock (INDP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Indaptus Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Indaptus Therapeutics Shares that will get you 0.4225 shares as per Indaptus Therapeutics share price of $3.55 per share as on September 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Indaptus Therapeutics Stock (INDP) from India?

Indian investors can start investing in Indaptus Therapeutics (INDP) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Indaptus Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Indaptus Therapeutics share’s latest price of $3.55 as on September 19, 2026 at 8:46 am IST, you will get 2.8169 shares of Indaptus Therapeutics. Learn more about fractional shares .

What are the returns that Indaptus Therapeutics has given to Indian investors in the last 5 years?

Indaptus Therapeutics stock has given -98.61% share price returns and 30.25% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?